Abstract
8 patients with plasmocytomas were treated with Endoxan and compared with 5 patients without any considerable treatment. Diagnosis, therapy and prognosis of plasmocytoma are discussed. Particularly mentioned are 3 patients with secondary tumours during cytostatic treatment, a plasmocytoma without paraprotein, a tumorous plasmocytoma with double paraproteinemia and a gammopathia with further development into a plasmocytoma 10 years later.
Publication types
-
Clinical Trial
-
Controlled Clinical Trial
-
English Abstract
MeSH terms
-
Aged
-
Alkylating Agents / therapeutic use
-
Cyclophosphamide / therapeutic use
-
Drug Therapy, Combination
-
Female
-
Humans
-
Hypergammaglobulinemia / complications
-
Immunoglobulin A
-
Immunoglobulin D
-
Immunoglobulin G
-
Immunoglobulin M
-
Male
-
Melphalan / therapeutic use
-
Middle Aged
-
Plasmacytoma / complications
-
Plasmacytoma / diagnosis*
-
Plasmacytoma / drug therapy
-
Prognosis
Substances
-
Alkylating Agents
-
Immunoglobulin A
-
Immunoglobulin D
-
Immunoglobulin G
-
Immunoglobulin M
-
Cyclophosphamide
-
Melphalan